… activation, and the mortality in COVID-19 patients (cluster 4). Our data are in line with Ma et
al. showing increased AP components in COVID-19 … AP activity and COVID-19 severity (22). …

… COVID-19-induced complement activation occurred via the lectin pathway, while activation of
the alternative pathway … higher COVID-19 severity and mortality (21). However, evidence of …

… Despite the excessive number of deaths resulting from the current pandemic COVID-19, very
few … Here, we described the massive activation of the lectin pathway, with consequences of …

… lectin pathway contributes to COVID-19 pathogenesis, we measured the plasma concentration
of 11 lectin … Black crosses mark patient deaths. Coloured bars show when patients met …

… Despite this, genetic variations in MBL2 are not associated with susceptibility to SARS-CoV-2
infection or disease outcomes such as mortality and the development of Long COVID. …

… deaths than previously expected due to the pandemic of coronavirus disease 2019 (COVID-19), …
called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Complement …

… therapy (RECOVERY) trial, demonstrated that dexamethasone reduced 28-day mortality in
patients on invasive mechanical ventilation by 28.7 % (29.0 % versus 40.7 % with usual care)…

… significant morbidity and mortality, as well … lectin pathway of complement activation, binds
to coronaviruses[5] and has been proposed to participate in the host defense during COVID-19 …

… The outbreak of COVID-19, a pandemic respiratory disease caused by SARS-CoV-2, is
responsible for critical health problems around the world, with a high rate of mortality, especially …

… progressed to severe COVID-19 pathology. This report demonstrates that lectin pathway (LP) …
to severe long-term morbidity and mortality, especially in patients with underlying medical …